Department of Biomaterials, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, P. R. China.
ACS Appl Mater Interfaces. 2022 Nov 2;14(43):48341-48355. doi: 10.1021/acsami.2c09612. Epub 2022 Oct 18.
Posterior capsular opacification (PCO) is the most common complication after cataract surgery, which is primarily caused by the proliferation of the residual lens epithelial cells (LECs) in the lens capsule. Previous studies have demonstrated that a drug-eluting intraocular lens (IOL), aimed to in situ eliminate LECs, are an effective and promising way to prevent PCO. However, because of the potential toxicities of the antiproliferative drugs to the adjacent tissues, the safety of such drug-eluting IOLs is still a highly important issue to be solved. In this investigation, a facile photodynamic coating-modified IOL was developed for effective and safer PCO prevention. An annular poly(lactide--glycolic acid) (PLGA) coating loaded with photosensitizer chlorin e6 (Ce6) was prepared by a spin-coating technique. The optical property investigations showed that the Ce6@PLGA coating was particularly suitable for the IOL surface modification. The in vitro cell culture investigation showed that Ce6@PLGA coating-modified IOLs effectively eliminated LECs when treated with light illumination, whereas it appeared to have good cytocompatibility without irradiation. The investigation of the cell elimination mechanism showed that the apoptosis of HLECs may be associated with the cytomembrane disruption induced by ROS, which is generated by the photodynamic coating during light illumination. The in vivo implantation experiments confirmed the desired PCO prevention effect, as well as the safety to and biocompatibility with the surrounding tissues. Thus, the facile Ce6@PLGA coating will provide an effective yet safe alternative of IOL surface modification for PCO prevention.
后囊膜混浊 (PCO) 是白内障手术后最常见的并发症,主要由晶状体囊内残留的晶状体上皮细胞 (LEC) 增殖引起。先前的研究表明,载药型人工晶状体 (IOL) 旨在原位消除 LEC,是预防 PCO 的一种有效且有前途的方法。然而,由于抗增殖药物对邻近组织的潜在毒性,此类载药型 IOL 的安全性仍然是一个亟待解决的重要问题。在这项研究中,开发了一种简便的光动力涂层修饰的 IOL,用于有效且更安全的 PCO 预防。采用旋涂技术制备了载有光敏剂氯己定 (Ce6) 的环形聚 (乳酸-羟基乙酸) (PLGA) 涂层。光学性质研究表明,Ce6@PLGA 涂层特别适合于 IOL 表面修饰。体外细胞培养研究表明,Ce6@PLGA 涂层修饰的 IOL 在光照下可有效消除 LEC,而在没有光照的情况下,其表现出良好的细胞相容性。细胞消除机制的研究表明,HLECs 的凋亡可能与 ROS 诱导的细胞内膜破裂有关,而 ROS 是光动力涂层在光照下产生的。体内植入实验证实了该方法具有良好的 PCO 预防效果,以及对周围组织的安全性和生物相容性。因此,简便的 Ce6@PLGA 涂层将为 IOL 表面修饰提供一种有效且安全的替代方法,用于 PCO 的预防。